CDSCO labs flag 211 drugs as ‘not of standard quality’ in Oct

The Central Drugs Standard Control Organisation (CDSCO) on Friday declared 211 drug samples tested by the Central and state drugs regulatory authorities as ‘Not of Standard Quality (NSQ)' in its monthly drug alert for October.

While the Central Drugs Laboratories identified 63 drug samples as NSQ, the State Drugs Testing Laboratories identified 148 drug samples as NSQ.

As part of routine regulatory surveillance activities, the list of NSQ and spurious drugs is displayed on the CDSCO portal on a monthly basis.

“For the month of October 2025, Central Drugs Laboratories have identified 63 Drug Samples to be Not of Standard Quality (NSQ) and State Drugs Testing Laboratories have identified 148 drug samples as Not of Standard Quality (NSQ),” the alert said.

Identification of drug samples as NSQ is done based on failure of the drug sample in one or the other specified quality parameters.

The failure is specific to the drug products of the batch tested by the government laboratory, and it does not warrant any concerns on the other drug products available in the market, the health officials said.